Adocia
ADOC | PA
Overview
Corporate Details
- ISIN(s):
- FR0011184241 (+1 more)
- LEI:
- 969500ZL79KYH9PTYP78
- Country:
- France
- Address:
- 115 AVENUE LACASSAGNE, 69003 LYON
- Website:
- https://www.adocia.com
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Adocia is a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. In the diabetes field, Adocia’s portfolio of injectable treatments is among the largest and most differentiated of the industry, featuring five clinical-stage products. Additionally, Adocia aims to expand its portfolio towards the treatment of other metabolic diseases and their comorbidities. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and/or safety of therapeutic proteins while making them easier for patients to use. Adocia customizes BioChaperone to each protein for a given application.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-12 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Inside Information / Other news releases
|
English | 492.1 KB | |
| 2025-06-12 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 491.7 KB | |
| 2025-05-22 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 452.1 KB | |
| 2025-05-22 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 472.2 KB | |
| 2025-05-21 18:00 |
General Meeting Notice
Informations privilégiées / Autres communiqués
|
French | 120.9 KB | |
| 2025-05-21 18:00 |
General Meeting Notice
Inside Information / Other news releases
|
English | 130.5 KB | |
| 2025-05-15 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Inside Information / Other news releases
|
English | 474.1 KB | |
| 2025-05-15 18:00 |
Declaration of Voting Results & Voting Rights Announcements
Informations privilégiées / Autres communiqués
|
French | 473.1 KB | |
| 2025-05-14 18:00 |
Earnings Release
Inside Information / News release on accounts, results
|
English | 576.9 KB | |
| 2025-05-14 18:00 |
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
|
French | 531.5 KB | |
| 2025-04-30 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 473.1 KB | |
| 2025-04-30 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 461.0 KB | |
| 2025-04-29 16:29 |
Annual Report (ESEF)
Document d'Enregistrement Universel 2024
|
French | 3.6 MB | |
| 2025-04-28 18:00 |
Regulatory News Service
Inside Information / Other news releases
|
English | 692.6 KB | |
| 2025-04-28 18:00 |
Regulatory News Service
Informations privilégiées / Autres communiqués
|
French | 682.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-21 | N/A | Other | Buy | 51,921 | 499,999.23 EUR |
| 2024-03-21 | N/A | Other | Buy | 15,576 | 149,996.88 EUR |
| 2023-12-29 | N/A | Other | Sell | 20,000 | 236,550.00 EUR |
| 2023-10-05 | N/A | Other | Sell | 50,000 | 400,000.00 EUR |
| 2023-09-20 | N/A | Other | Sell | 36,240 | 291,376.85 EUR |
| 2023-07-28 | N/A | Other | Buy | 220,264 | 999,998.56 EUR |
| 2023-07-28 | N/A | Other | Buy | 110 | 499.40 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
BioArctic | Sweden | BIOA | |
|
Bioceltix S.A. | Poland | BCX | |
|
Bioextrax AB | Sweden | BIOEX | |
|
Biofrontera AG | Germany | B8F | |
|
BioGaia | Sweden | BIOG | |
|
Biohit Oyj | Finland | BIOBV | |
|
BioInvent International | Sweden | BINV | |
|
BioLineRx Ltd. | Israel | BLRX | |
|
Biophytis S.A. | France | ALBPS | |
|
BioPorto | Denmark | BIOPOR |